Consistent efficacy and safety of erenumab over time in patients with episodic migraine who completed a 5-year, open-label extension study

被引：0

作者：

Ashina, M. ^{[1
]}

Goadsby, P. J. ^{[2
,3
]}

Reuter, U. ^{[4
]}

Silberstein, S. D. ^{[5
]}

Dodick, D. W. ^{[6
]}

Zhang, F. ^{[7
]}

Xui, F. ^{[7
]}

Cheng, S. ^{[7
]}

Chou, D. E. ^{[7
]}

Lima, G. Paiva Da Silva ^{[7
]}

机构：

[1] Univ Copenhagen, Copenhagen, Denmark

[2] Kings Coll London, London, England

[3] Univ Calif Los Angeles, Los Angeles, CA USA

[4] Charite, Berlin, Germany

[5] Thomas Jefferson Univ, Jefferson Headache Ctr, Philadelphia, PA 19107 USA

[6] Mayo Clin, Scottsdale, AZ USA

[7] Amgen Inc, Thousand Oaks, CA 91320 USA

来源：

CEPHALALGIA | 2021年 / 41卷 / 1_SUPPL期

关键词：

D O I：

暂无

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

AL049

引用

页码：25 / 26

页数：2

共 50 条

[1] Consistent efficacy and safety of erenumab over time in patients with episodic migraine who completed a 5-year, open-label extension study
Ashina, M.
Goadsby, P. J.
Reuter, U.
Silberstein, S. D.
Dodick, D. W.
Zhang, F.
Xui, F.
Cheng, S.
Chou, D. E.
Lima, G. Paiva Da Silva
[J]. JOURNAL OF HEADACHE AND PAIN, 2021, 22 (SUPPL 1): : 17 - 17
[2] Consistent efficacy and safety of erenumab over time in patients with episodic migraine who completed a 5-year, open-label extension study
Ashina, Messoud
Goadsby, Peter
Reuter, Uwe
Silberstein, Stephen
Dodick, David
Zhang, Feng
Xue, Fei
Cheng, Sunfa
Chou, Denise
Lima, Gabriel Paiva da Silva
[J]. NEUROLOGY, 2021, 96 (15)
[3] Consistent efficacy and safety of erenumab over time in patients with episodic migraine who completed a 5-year, open-label extension study
Ashina, M.
Goadsby, P. J.
Reuter, U.
Silberstein, S. D.
Dodick, D. W.
Zhang, F.
Xue, F.
Cheng, S.
Chou, D. E.
Lima, da Silva G. P.
[J]. HEADACHE, 2021, 61 : 117 - 118
[4] Consistent efficacy and safety of erenumab in episodic migraine patients during a 5-year, open-label extension study
Ashina, M.
Goadsby, P.
Reuter, U.
Silberstein, S.
Dodick, D.
Zhang, F.
Xue, F.
Cheng, S.
Chou, D.
Lima, G. Paiva da Silva
[J]. EUROPEAN JOURNAL OF NEUROLOGY, 2021, 28 : 153 - 154
[5] SUSTAINED EFFICACY AND LONG-TERM SAFETY OF ERENUMAB IN PATIENTS WITH EPISODIC MIGRAINE: RESULTS OF A 5-YEAR, OPEN-LABEL EXTENSION STUDY
Ashina, Messoud
Goadsby, Peter J.
Reuter, Uwe
Silberstein, Stephen
Dodick, David W.
Xue, Fei
Zhang, Feng
Cheng, Sunfa
Chou, Denise E.
Lima, Gabriel Paiva da Silva
[J]. CEPHALALGIA, 2020, 40 : 60 - 61
[6] Sustained Efficacy and Long-term Safety of Erenumab in Patients with Episodic Migraine: 4+Year Results of a 5-Year, Open-Label Extension Study
Ashina, M.
Goadsby, P. J.
Reuter, U.
Silberstein, S. D.
Dodick, D. W.
Chou, D. E.
Klatt, J.
Xue, F.
Zhang, F.
Cheng, S.
Mikol, D. D.
[J]. HEADACHE, 2019, 59 : 25 - 25
[7] Sustained Efficacy and Long-term Safety of Erenumab in Patients with Episodic Migraine: 4+Year Results of a 5-year, Open-label Treatment Period
Ashina, Messoud
Goadsby, Peter
Reuter, Uwe
Silberstein, Stephen
Dodick, David
Xue, Fei
Zhang, Feng
Cheng, Sunfa
Mikol, Daniel
[J]. NEUROLOGY, 2020, 94 (15)
[8] Sustained efficacy and long-term safety of erenumab in patients with episodic migraine: 4+year results of a 5-year, open-label treatment period
Ashina, Messoud
Goadsby, Peter J.
Reuter, Uwe
Silberstein, Stephen
Dodick, David W.
Chou, Denise E.
Pandhi, Shaloo
Xue, Fei
Zhang, Feng
Cheng, Sunfa
Mikol, Daniel D.
[J]. CEPHALALGIA, 2019, 39 (1_SUPPL) : 365 - 366
[9] Long-term efficacy and safety during open-label erenumab treatment in Japanese patients with episodic migraine
Sakai, Fumihiko
Takeshima, Takao
Tatsuoka, Yoshihisa
Hirata, Koichi
Cheng, Sunfa
Numachi, Yotaro
Peng, Cheng
Xue, Fei
Mikol, Daniel D.
[J]. HEADACHE, 2021, 61 (04): : 653 - 661
[10] Sustained Efficacy and Safety of Erenumab in Patients With Episodic Migraine Who Failed 2-4 Prior Preventive Treatments: 2-Year Interim Results of the LIBERTY Open-label Extension Study
Reuter, U.
Goadsby, P. J.
Lanteri-Minet, M.
Stites, T.
Wen, S.
Tenenbaum, N.
Ferrari, M.
Pandhi, S.
[J]. HEADACHE, 2020, 60 : 96 - 97

← 1 2 3 4 5 →